Assessment of HIV molecular surveillance capacity in the European Union, 2016

Expanding access to HIV antiretroviral treatment is expected to decrease HIV incidence and acquired immunodeficiency syndrome (AIDS) mortality. However, this may also result in increased HIV drug resistance (DR). Better monitoring and surveillance of HIV DR is required to inform treatment regimens a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Euro Surveill
Autores principales: Keating, Patrick, Pharris, Anastasia, Leitmeyer, Katrin, De Angelis, Stefania, Wensing, Annemarie, Amato-Gauci, Andrew J, Broberg, Eeva
Formato: Artigo
Lenguaje:Inglês
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727594/
https://ncbi.nlm.nih.gov/pubmed/29233253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2017.22.49.17-00269
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares